This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

GLYCAR Post Market Multicenter Study

Sponsored by GLYCAR SA (Pty) Ltd

About this trial

Last updated 9 months ago

Study ID

GLYCAR

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
All
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 2 years ago

What is this trial about?

Prospective, non-interventional, observational, multi-center, single arm, post market clinical follow-up study

What are the participation requirements?

Yes

Inclusion Criteria

- Patients (to be) treated with Glycar Pericardial patch as per IFU and standard clinical practice. - The patient or patient's legal representative signs an EC/ IRB approved informed consent form prior to the study participation Intraprocedural inclusion: GLYCAR Pericardial Patch was implanted, or implantation attempted during the index procedure.

No

Exclusion Criteria

- No study specific exclusion criteria: patients treated per standard clinical practice and do not present any of the contraindications detailed in the IFU.